| Dr Desmond Erasmus, MD | |
|
2500 Mowry Avenue, #222, Fremont, CA 94538-1605 | |
| (510) 818-1160 | |
| (510) 818-1195 |
| Full Name | Dr Desmond Erasmus |
|---|---|
| Gender | Male |
| Speciality | Neurological Surgery |
| Location | 2500 Mowry Avenue, Fremont, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386744779 | NPI | - | NPPES |
| 4787816 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | A34539 (California) | Primary |
| Entity Name | Washington Township Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346557014 PECOS PAC ID: 2860687050 Enrollment ID: O20101112001225 |
News Archive
GTx, Inc. today reported financial results for the third quarter of 2011. The net loss for the quarter ended September 30, 2011 was $9.3 million compared with a net loss of $8.6 million for the quarter ended September 30, 2010, reflecting increased research and development costs in connection with the Company's Ostarine™ and Capesaris™ clinical development programs.
Genzyme Corporation has announced that its Premarket Approval (PMA) application supplement for Synvisc-One (hylan G-F 20) will be discussed this Tuesday, December 9th, at a public meeting of the FDA's Orthopaedic and Rehabilitation Devices Advisory Committee in Gaithersburg, Maryland.
Myasthenia Gravis (MG) is a debilitating and potentially deadly disease that can afflict anyone, characterized by severe muscle weakness, affecting control of facial expressions, arm and leg movements, chewing, swallowing, coughing and breathing. There is no cure, only treatment.
According to a new study, smoking was found to have a strong association with the presence of flat adenomas (precancerous polyps) in the colon and may explain the earlier onset of colorectal cancer in smokers, as well as the advanced stage with which they present when compared to nonsmokers. Flat adenomas are more difficult to detect and have more aggressive pathology than the typical raised type of polyp detected during colorectal cancer screening.
Oncolytics Biotech Inc. announced today that the Cancer Therapy & Research Center at the University of Texas Health Science Center in San Antonio (CTRC) has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with gemcitabine (Gemzar(R)) in patients with advanced pancreatic cancer. The Principal Investigator is Dr. Monica Mita of the CTRC.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Desmond Erasmus, MD 2500 Mowry Avenue, #222, Fremont, CA 94538-1605 Ph: (510) 818-1160 | Dr Desmond Erasmus, MD 2500 Mowry Avenue, #222, Fremont, CA 94538-1605 Ph: (510) 818-1160 |
News Archive
GTx, Inc. today reported financial results for the third quarter of 2011. The net loss for the quarter ended September 30, 2011 was $9.3 million compared with a net loss of $8.6 million for the quarter ended September 30, 2010, reflecting increased research and development costs in connection with the Company's Ostarine™ and Capesaris™ clinical development programs.
Genzyme Corporation has announced that its Premarket Approval (PMA) application supplement for Synvisc-One (hylan G-F 20) will be discussed this Tuesday, December 9th, at a public meeting of the FDA's Orthopaedic and Rehabilitation Devices Advisory Committee in Gaithersburg, Maryland.
Myasthenia Gravis (MG) is a debilitating and potentially deadly disease that can afflict anyone, characterized by severe muscle weakness, affecting control of facial expressions, arm and leg movements, chewing, swallowing, coughing and breathing. There is no cure, only treatment.
According to a new study, smoking was found to have a strong association with the presence of flat adenomas (precancerous polyps) in the colon and may explain the earlier onset of colorectal cancer in smokers, as well as the advanced stage with which they present when compared to nonsmokers. Flat adenomas are more difficult to detect and have more aggressive pathology than the typical raised type of polyp detected during colorectal cancer screening.
Oncolytics Biotech Inc. announced today that the Cancer Therapy & Research Center at the University of Texas Health Science Center in San Antonio (CTRC) has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with gemcitabine (Gemzar(R)) in patients with advanced pancreatic cancer. The Principal Investigator is Dr. Monica Mita of the CTRC.
› Verified 4 days ago
Dr. Rajiv Saigal, M.D., PH.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 Mowry Ave Ste 222, Fremont, CA 94538 Phone: 510-248-1160 | |
Stanton Schiffer, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3868 Mowry Ave, Fremont, CA 94538 Phone: 510-792-2911 Fax: 510-794-7924 | |
Dr. Sandeep Kunwar, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 Mowry Ave, Suite 222, Fremont, CA 94538 Phone: 510-818-1160 | |
Dr. Jeffrey E Thomas, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 Mowry Ave, Suite 222, Fremont, CA 94538 Phone: 510-818-1160 Fax: 510-818-1195 | |
Eldan B Eichbaum, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 Mowry Ave, Suite 222, Fremont, CA 94538 Phone: 510-818-1160 Fax: 510-818-1195 |